COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,588 Articles (22,415 medRxiv, 8,173 bioRxiv)

Most recent first Previous |  Page 1747: Articles 17461-17470  | Next

Accelerating COVID-19 research with graph mining and transformer-based learning
Tyagin, I., Kulshrestha, A., Sybrandt, J., Matta, K., Shtutman, M., Safro, I.
10.1101/2021.02.11.430789 — Posted: 2021-02-11
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
S Arunachalam, P., Walls, A. C., Golden, N., Atyeo, C., Fischinger, S., Li, C., Aye, P., Navarro, M. J., Lai, L., Edara, V. V., Roltgen, K., Rogers, K., Shirreff, L., Ferrell, D. E., Wrenn, S., Pettie, D., Kraft, J. C., Miranda, M. C., Kepl, E., Sydeman, C., Brunette, N., Murphy, M., Fiala, B., Carter, L., White, A. G., Trisal, M., Hsieh, C.-L., Russell-Lodrigue, K., Monjure, C., Dufour, J., Doyle-Meyer, L., Bohm, R. B., Maness, N. J., Roy, C., Plante, J. A., Plante, K. S., Zhu, A., Gorman, M. J., Shin, S., Shen, X., Fontenot, J., Gupta, S., O Hagan, D. T., Most, R. V. D., Rappuoli, R., Coffman, R. L., Novack, D., McLellan, J. S., Subramaniam, S., Montefiori, D., Boyd, S. D., Flynn, J. L., Alter, G., Villinger, F., Kleanthous, H., Rappaport, J., Suthar, M., King, N. P., Veesler, D., Pulendran, B.
10.1101/2021.02.10.430696 — Posted: 2021-02-11
Differential roles of RIG-I-like receptors in SARS-CoV-2 infection
Yang, D., Geng, T., Harrison, A. G., WANG, P.
10.1101/2021.02.10.430677 — Posted: 2021-02-11
Bifurcated monocyte states are predictive of mortality in severe COVID-19
Cillo, A. R., Somasundaram, A., Shan, F., Cardello, C., Workman, C. J., Kitsios, G. D., Ruffin, A., Kunning, S., Lampenfeld, C., Onkar, S., Grebinowski, S., Deshmukh, G., Methe, B., Liu, C., Nambulli, S., Andrews, L., Duprex, W. P., Joglekar, A. J., Benos, P. V., Ray, P., Ray, A., McVerry, B. J., Zhang, Y., Lee, J. S., Das, J., Singh, H., Morris, A., Bruno, T. C., Vignali, D. A.
10.1101/2021.02.10.430499 — Posted: 2021-02-10
In vitro evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2
Szemiel, A. M., Merits, A., Orton, R. J., MacLean, O., Wickenhagen, A., Lieber, G., Pinto, R. M., Turnbull, M. L., Wang, S., Mair, D., da Silva Filipe, A., Willett, B. J., Wilson, S. J., Patel, A. H., Thomson, E. C., Palmarini, M., Kohl, A., Stewart, M. E.
10.1101/2021.02.01.429199 — Posted: 2021-02-10
SARS-CoV-2 infection models using in vivo and in vitro hACE2-lentivirus transduction
Rawle, D. J., Le, T. T., Dumenil, T., Yan, K., Tang, B., Bishop, C., Suhrbier, A.
10.1101/2021.02.09.430547 — Posted: 2021-02-10
Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain
Feldman, J., Bals, J., Denis, K. S., Lam, E. C., Hauser, B. M., Ronsard, L., Sangesland, M., Moreno, T. B., Okonkwo, V., Hartojo, N., Balazs, A. B., Lingwood, D., Schmidt, A. G.
10.1101/2021.02.02.429458 — Posted: 2021-02-10
Susceptibility and risk of suffering SARS-COV-2 infection by demographic characteristics and pre-existing medical conditions among middle-aged and older adults in Tarragona, Spain: results from the COVID19 TARRACO Cohort Study, March-June 2020
SATUE-GRACIA, E. M., Vila-Corcoles, A., De Diego-Cabanes, C., Vila, A., Torrente-Fraga, C., Gomez-Bertomeu, F., Hospital-Guardiola, I., Ochoa-Gondar, O., Martin-Lujan, F.
10.1101/2021.02.09.21251398 — Posted: 2021-02-10
Estimating the proportion of SARS-CoV-2 infections reported through diagnostic testing
Colman, E., Enright, J., Puspitarani, G. A., Kao, R. R.
10.1101/2021.02.09.21251411 — Posted: 2021-02-10 Discussion: Onsite
Detection Of Genomic Variants Of SARS-CoV-2 Circulating In Wastewater By High-Throughput Sequencing
Perez-Cataluna, A., Chiner-Oms, A., Cuevas-Ferrando, E., Diaz-Reolid, A., Falco, I., Randazzo, W., Giron-Guzman, I., Allende, A., Bracho, M. A., Comas Espadas, I., Sanchez, G.
10.1101/2021.02.08.21251355 — Posted: 2021-02-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).